
DEPT
FACULTY
COVID-19 Contribution
19 Jan 2023
Background: While different COVID-19 vaccines have been developed, there has been lack of data on the efficacy comparison between mRNA and inactivated...Read more
01 Sep 2020
Background: Chronic respiratory diseases are risk factors for severe disease in coronavirus disease 2019 (COVID-19). Respiratory tract infection is on...Read more
23 Feb 2023
While molnupiravir (MOV) and nirmatrelvir–ritonavir (NMV-r) were developed for treatment of mild to moderate COVID-19 infection, there has been a lack...Read more
01 Apr 2022
Background: Chronic illnesses were reported to be poor prognostic factors associated with severe illness and mortality in Coronavirus disease 2019 (CO...Read more
01 Dec 2021
Background: Coronavirus Disease 2019 (COVID-19) led to pandemic that affected almost all countries in the world. Many countries have implemented borde...Read more
01 Oct 2021
Rationale: Patients with asthma were advised to avoid coronavirus disease (COVID-19) and comply with medication during the COVID-19 pandemic. Respirat...Read more
01 Dec 2021
It was highlighted that the in the original article the name of Chun-Ka Wong was incorrectly shown as Ka- Chun Wong. The original article has been upd...Read more
14 Feb 2023
Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong
Background While there are postulations that asthma is potentially associated with severe coronavirus disease 2019 (COVID-19), there has been conflict...Read more